[HTML][HTML] Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats

SJ Jiang, H Dong, JB Li, LJ Xu, X Zou… - World Journal of …, 2015 - ncbi.nlm.nih.gov
AIM: To investigate the molecular mechanisms of berberine inhibition of hepatic
gluconeogenesis in a diabetic rat model. METHODS: The 40 rats were randomly divided into …

Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis

M Zhang, X Lv, J Li, Z Meng, Q Wang… - Molecular and Cellular …, 2012 - Elsevier
Berberine (BER), a natural product and active ingredient of genera Berberis and Coptis, has
been demonstrated to possess anti-diabetic activities. However, the poor bioavailability of …

Berberine attenuates fructose-induced insulin resistance by stimulating the hepatic LKB1/AMPK/PGC1α pathway in mice

Y Li, B Wang, J Shen, M Bai, E Xu - Pharmaceutical Biology, 2020 - Taylor & Francis
Context Berberine is an alkaloid that possesses various pharmacologic effects. Objective To
explore the mechanism of berberine to improve insulin sensitivity in fructose-fed mice …

Berberine ameliorates hyperglycemia in alloxan-induced diabetic C57BL/6 mice through activation of Akt signaling pathway

X Xie, W Li, T Lan, W Liu, J Peng, K Huang… - Endocrine …, 2011 - jstage.jst.go.jp
1) Laboratory of Pharmacology & Toxicology, School of Pharmaceutical Sciences, Sun Yat-
Sen University, Guangzhou 510006, China 2) Chengdu Military General Hospital, Chengdu …

Berberine improves glucose metabolism in diabetic rats by inhibition of hepatic gluconeogenesis

X Xia, J Yan, Y Shen, K Tang, J Yin, Y Zhang, D Yang… - PLoS one, 2011 - journals.plos.org
Berberine (BBR) is a compound originally identified in a Chinese herbal medicine
Huanglian (Coptis chinensis French). It improves glucose metabolism in type 2 diabetic …

[HTML][HTML] Berberine regulated Gck, G6pc, Pck1 and Srebp-1c expression and activated AMP-activated protein kinase in primary rat hepatocytes

Y Ge, Y Zhang, R Li, W Chen, Y Li… - International Journal of …, 2011 - ncbi.nlm.nih.gov
The effects of hormonal and dietary stimuli on hepatic glucose and lipid homeostasis include
regulation of gene expression. Berberine, an effective compound in certain Chinese …

Berberine attenuates hyperglycemia by inhibiting the hepatic glucagon pathway in diabetic mice

Y Zhong, J Jin, P Liu, Y Song, H Zhang… - Oxidative Medicine …, 2020 - Wiley Online Library
Dysregulated glucagon drives hyperfunction in hepatic glucose output, which is the main
cause of persistent hyperglycemia in type 2 diabetes. Berberine (Zhang et al., 2010) has …

Effect of berberine on the HPA-axis pathway and skeletal muscle GLUT4 in type 2 diabetes mellitus rats

J Mi, W He, J Lv, K Zhuang, H Huang… - … Syndrome and Obesity …, 2019 - Taylor & Francis
Purpose Activation of the hypothalamus-pituitary-adrenal (HPA) axis pathway is closely
related to insulin resistance (IR), glucose, and lipid metabolism disorders in type 2 diabetes …

Berberine moderates glucose metabolism through the GnRH-GLP-1 and MAPK pathways in the intestine

Q Zhang, X Xiao, M Li, W Li, M Yu, H Zhang… - … and Alternative Medicine, 2014 - Springer
Background Berberine is known to improve glucose and lipid metabolism disorders, but it
poorly absorbed into the blood stream from the gut. Therefore, the exact underlying …

Berberine inhibits mouse insulin gene promoter through activation of AMP activated protein kinase and may exert beneficial effect on pancreatic β-cell

N Shen, Y Huan, Z Shen - European Journal of Pharmacology, 2012 - Elsevier
Berberine is one of the main alkaloids of Rhizoma coptidis, proven to have anti-diabetic
potentials through activation of AMP activated protein kinase (AMPK) in liver and muscle …